Navigation Links
Deadly fish virus now found in all Great Lakes
Date:1/27/2010

ITHACA, N.Y. A deadly fish virus that was first discovered in the Northeast in 2005 has been found for the first time in fish from Lake Superior, report Cornell researchers. That means that the virus has now been documented in all of the Great Lakes.

The viral hemorrhagic septicemia virus (VHSV), which causes fatal anemia and hemorrhaging in many fish species, poses no threat to humans, said Paul Bowser, professor of aquatic animal medicine at Cornell's College of Veterinary Medicine.

Bowser and colleagues recently tested 874 fish from seven sites in Lake Superior in collaboration with the U.S. Geological Survey (USGS) Western Fisheries Research Center in Seattle. Fish from Paradise and Skanee in Michigan and St. Louis Bay and Superior Bay in Wisconsin tested positive. Some of the results have been corroborated by other laboratories; others have tests still under way.

The virus, which has been identified in 28 freshwater fish species in the Great Lakes watershed, has reached epidemic proportions in the Great Lakes and threatens New York's sport-fishing industry, said Bowser, estimated to contribute some $1.4 billion annually to New York's economy.

"People come from all over the eastern United States to fish the Great Lakes," said Bowser, noting that the virus has also been found in a few inland waters as well, including lakes, streams and a family-owned earthen pond.

"The economy of many of these areas ebbs and flows with the season and perceived value of outdoor recreational opportunities. The value of these opportunities is dependent on how successful we are at managing the health of wild fish. On a worldwide basis, VHSV is considered one of the most serious pathogens of fish, because it kills so many fish, is not treatable and infects a broad range of fish species."

In 2008 the U.S. Department of Agriculture issued a federal order preventing transport of the 28 species within the Great Lakes watershed, including Lake Superior, to limit the spread of this viral pathogen. As a result, the new findings will not lead to additional regulatory actions, according to authorities.

While no significant fish mortality due to VHSV was observed in 2008 and 2009, "It is important to note that there are still fish harboring VHSV; essentially the infection proceeds even though no mortalities are being observed," said Bowser. "This is important because it suggests that these infected fish may serve as a reservoir for the virus in the Great Lakes ecosystem. While we don't fully understand the lack of recent mortality, the potential presence or absence of stressors on the fish may be playing a role."


'/>"/>

Contact: Joe Schwartz
bjs54@cornell.edu
607-254-6235
Cornell University
Source:Eurekalert

Related biology news :

1. Disarming specialized stem cells might combat deadly ovarian cancer
2. Iowa State University researcher discovers Ebolas deadly secret
3. A deadly scorpion provides a safe pesticide
4. U of Alberta researchers find mechanism that could prevent or treat deadly peroxisome diseases
5. A trip to the candy store might help ward off rare, but deadly infections
6. New compounds may control deadly fungal infections
7. Compound found to safely counter deadly bird flu
8. USU scientists report major advance in human antibody therapy against deadly Nipah virus
9. Satellite data look behind the scenes of deadly earthquake
10. New hope for deadly childhood bone cancer
11. Komodo even more deadly than thought: Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... 2017  Aware, Inc. (NASDAQ: AWRE ), a ... results for its quarter and year ended December 31, 2016. ... was $3.9 million compared to $6.9 million in the same ... 2016 was $0.6 million compared to $2.6 million in the ... of 2016 was $0.5 million, or $0.02 per diluted share, ...
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... 2021 from $8.3 billion in 2016 at a compound ... 2021. Report Includes - An overview of the ... trends, with data from 2015 and 2016, and projections ... Segmentation of the market on the basis of product ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... WEST PALM BEACH, Fla. , Feb. 16, ... molecular diagnostics company revolutionizing the development of liquid ... that it has entered into an exclusive license ... who will distribute MDNA,s proprietary liquid biopsy test ... in South Korea . This ...
(Date:2/16/2017)... 16, 2017   Biostage, Inc. (Nasdaq: ... company developing bioengineered organ implants to treat cancers and ... announced today the closing on February 15, 2017 of ... common stock and warrants to purchase 20,000,000 shares of ... The offering was priced at $0.40 per share of ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... and NEW YORK , Feb. 16, ... completion of their $7M Series B financing, adding an ... the $3.5M led by Mesa Verde Venture Partners and ... resources will be directed towards further accelerating commercial adoption ... comprehensive genomic profiling test and expanding the Paradigm cancer ...
Breaking Biology Technology: